Wearable Devices Ltd. Sells 440,000 Shares in Direct Offering
Ticker: WLDSW · Form: 6-K · Filed: Sep 15, 2025 · CIK: 1887673
| Field | Detail |
|---|---|
| Company | Wearable Devices Ltd. (WLDSW) |
| Form Type | 6-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $6.00, $5.9999, $0.0001, $50,000, $4 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: offering, capital-raise, shares
TL;DR
Wearable Devices Ltd. is selling 440K shares to an institutional investor via a direct offering.
AI Summary
On September 12, 2025, Wearable Devices Ltd. entered into a Securities Purchase Agreement with an institutional investor to sell 440,000 ordinary shares in a registered direct offering. The filing is a Report of Foreign Private Issuer for the month of September 2025.
Why It Matters
This registered direct offering indicates the company is raising capital, potentially for expansion or operational needs, directly from an institutional investor.
Risk Assessment
Risk Level: medium — Direct offerings can dilute existing shareholders and signal a need for capital, which may impact stock price.
Key Numbers
- 440,000 — Ordinary Shares (Number of shares sold in the registered direct offering)
Key Players & Entities
- Wearable Devices Ltd. (company) — Registrant
- September 12, 2025 (date) — Date of Securities Purchase Agreement
- 440,000 (dollar_amount) — Number of ordinary shares to be sold
FAQ
What is the total value of the registered direct offering?
The filing does not specify the price per share or the total dollar amount of the offering, only that 440,000 ordinary shares will be sold.
Who is the institutional investor purchasing the shares?
The filing refers to the purchaser only as 'a single institutional investor' and does not disclose their name.
What is the purpose of this registered direct offering?
The filing does not explicitly state the purpose of the offering, but it is a common method for companies to raise capital.
When was the Securities Purchase Agreement entered into?
The Securities Purchase Agreement was entered into on September 12, 2025.
What type of shares are being offered?
The company is offering its ordinary shares, no par value per share.
Filing Stats: 1,741 words · 7 min read · ~6 pages · Grade level 13.4 · Accepted 2025-09-15 07:29:48
Key Financial Figures
- $6.00 — Shares”), at an offering price of $6.00 per share; and (ii) pre-funded warrants
- $5.9999 — arrants”) at an offering price of $5.9999 per Pre-Funded Warrant. The Pre-Funded
- $0.0001 — Ordinary Share at an exercise price of $0.0001 per share. The Pre-Funded Warrants are
- $50,000 — the offering in an amount not to exceed $50,000. The foregoing summaries of the Placem
- $4 Million — o;Wearable Devices Announces Pricing of $4 Million Registered Direct Offering and Concurre
Filing Documents
- ea0257315-6k_wearable.htm (6-K) — 27KB
- ea025731501ex4-1_wearable.htm (EX-4.1) — 117KB
- ea025731501ex4-2_wearable.htm (EX-4.2) — 84KB
- ea025731501ex5-1_wearable.htm (EX-5.1) — 12KB
- ea025731501ex5-2_wearable.htm (EX-5.2) — 11KB
- ea025731501ex10-1_wearable.htm (EX-10.1) — 48KB
- ea025731501ex10-2_wearable.htm (EX-10.2) — 239KB
- ea025731501ex99-1_wearable.htm (EX-99.1) — 12KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- ex5-1_002.jpg (GRAPHIC) — 2KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-087408.txt ( ) — 562KB
Forward-Looking Statements
Forward-Looking Statements : This Report contains forward-looking other federal securities laws. For example, the Company is using forward-looking statements when it discusses the closing of the Offering. All statements other than statements of historical facts included in this Report are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include the risks and uncertainties described in the Company’s annual report on Form 20-F for the year ended December 31, 2024, filed with the Commission on March 20, 2025, and the Company’s other filings with the Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. 2 EXHIBIT INDEX Exhibit No. Description 4.1 Form of Ordinary Warrant. 4.2 Form of Pre-Funded Warrant. 5.1 Opinion of Sullivan & Wor
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Wearable Devices Ltd. Date: September 15, 2025 By: /s/ Asher Dahan Asher Dahan Chief Executive Officer